MAD2L1 and hepatocellular carcinoma: Furthermore, when MAD2 was blocked by its specific inhibitor M2I-1, highly aggressive malignant behaviors of HCC cells caused by overexpression of SGOL2 were significantly reversed (Fig. 3C-D).